.
π¦ What is Hepatitis B
Hepatitis B is a viral infection caused by the Hepatitis B virus (HBV) that primarily affects the liver.
Transmission: Blood, sexual contact, perinatally (from mother to baby at birth), sharing needles, etc.
Virus type: DNA virus (Hepadnaviridae family)
Incubation period: 1β4 months
π Modes of Transmission
Route Description
Vertical Mother to child (most common in pregnancy)
Horizontal Blood products, sexual contact, needle use
π Clinical Phases
Acute Hepatitis B
Often asymptomatic
Symptoms (if present): fatigue, nausea, jaundice, dark urine, RUQ pain
May resolve or progress to chronic infection
Chronic Hepatitis B
Persistence of HBsAg 6 months
Risk of cirrhosis, liver failure, and hepatocellular carcinoma (HCC)
π§ͺ Serology Markers
Marker Interpretation
HBsAg Active infection (acute or chronic
Anti-HBs Immunity (from vaccine or past infection
Anti-HBc Exposure to virus IgM = recent; IgG = past
HBeAg High infectivity
HBV DNA Viral load β used to guide treatment
π€° Hepatitis B in Pregnancy
Key Concerns:
Mother-to-child transmission (MTCT) is the most common mode in endemic areas.
Transmission risk:
90% if mother is HBeAg+
10β30% if HBeAg-
Prevention of MTCT:
Screen all pregnant women for HBsAg during first prenatal visit.
If mother is HBsAg positive:
Infant should receive:
HBV vaccine + Hepatitis B immunoglobulin (HBIG) within 12 hours of birth
Continue vaccine series at 1 and 6 months
If mother has high viral load 200,000 IU/mL
Start antiviral therapy Tenofovi at 28β32 weeks gestation
π Treatment Overview
In pregnancy:
Tenofovir disoproxil fumarate is preferred β safe and effective
Monitor liver function tests FTs and HBV DNA levels
In non-pregnant adults:
Tenofovir, entecavir, pegylated interferon not for pregnancy
π¨ Complications of Chronic Hepatitis B
Liver cirrhosis
Hepatocellular carcinoma
Liver failure
Portal hypertension
Variceal bleeding
β
Summary
Aspect Key Points
Screening All pregnant women: HBsAg at first prenatal visit
Prevention in baby HBV vaccine + HBIG within 12 hrs of birth
Antivirals in mom Tenofovir if HBV DNA 200,000 IU/mL
Breastfeeding Safe if baby received vaccine + HBIG
Long-term monitoring For chronic HBV liver function and HCC screening
Would you like a slide format, table format, or a printable study sheet for this